Searched for
ONCO THERAPIES LIMITED
Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsGiven multiple issues that have suddenly come up, there is a high probability that the market will remain volatile. But history tells us th...
Strong balance sheet, brand & management are enough to create wealth: 8 stocks with upside potential from just 2% to 32%A good stock is only good in a time frame – the time frame in which it gets you returns. A good company is one which fares well even in a d...
Covid outbreak hinders cancer treatment in hospitalsOncologists recommend deferment of non-critical surgeries, radiation and chemotherapy sessions taking into account the low immunity levels ...
‘FedEx’ for cancer medicine, Cyca OncoSolutions wants to reduce the side effects of treatmentCan chemotherapy be directed at only the cancerous cells and not destroy the healthy ones? Nusrat Sanghamitra's entrepreneurship story may ...
We're here to stay, open to buy right portfolio: Rajiv Malik, President, MylanMylan is committed to staying in India and plans to build up its presence gradually while remaining open to acquisition, says Rajiv Malik.
Department of Industrial Policy and Promotion may seek FDI ban on critical drug unitsDIPP backed by the health min, may pitch for barring foreign direct investment in existing rare and critical domestic drug making facilitie...
CCI gives green signal to Strides Arcolab-Mylan dealCCI has approved the acquisition of a Strides Arcolab subsidiary by Mylan, saying the deal will not have an adverse impact on competition i...
- Strides Arcolab hits 52-week high on US FDA approval for Ifosfamide injection
Strides Arcolab Ltd surged over 2 per cent in trade on Thursday after Onco Therapies received ANDA approval for Ifosfamide Injection.
- Strides Arcolab, US FDA, Polymyxin B, Onco Therapies
Bangalore-based Strides Arcolab received European and US FDA approval on Friday for two of its products.